查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1599623

女性健康市场：按年龄、分销管道和应用分类 - 全球预测 2025-2030

Women's Health Market by Age (13-17 Years, 18-35 Years, 36 Years & Above), Distribution Channel (Hospital, Online, Retail), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

根据预测，2023年女性健康市场价值为432.3亿美元，预计到2024年将达到469.9亿美元，复合年增长率为8.97%，到2030年将达到789亿美元。

女性健康市场包括广泛的产品和服务，旨在满足女性整个生命阶段的独特健康需求。此细分市场包括针对生殖健康、更年期、骨质疏鬆症和营养缺乏等领域的药品、医疗设备、健康产品、诊断和整体健康服务。女性的健康需求植根于影响乳癌、妇科疾病和心理健康等疾病的独特生物和荷尔蒙因素，这些因素需要专门的产品和治疗。该市场由医疗机构、居家照护和专科诊所的应用推动，满足包括少女、年轻女性、孕妇和老年人在内的广泛最终用户的需求。影响市场成长的主要因素包括慢性病盛行率的上升、医疗保健意识的提高以及医疗保健服务的技术进步。

主要市场统计
基准年[2023] 432.3亿美元
预测年份 [2024] 469.9亿美元
预测年份 [2030] 789亿美元
复合年增长率（%） 8.97%

随着女性人口老化以及人们对预防性医疗保健的日益重视，个人化医疗和远端医疗面临着巨大的机会。公司可以透过投资人工智慧主导的诊断和穿戴式健康追踪器来利用这些趋势。此外，向天然和有机健康解决方案的转变为创新提供了成长空间。然而，市场面临严格的法规环境、高昂的研发成本以及限制获得医疗保健的社会经济差异等挑战。

最佳创新领域包括开发个人化、非侵入性诊断工具，特别是针对荷尔蒙和生殖系统疾病的诊断工具，以及提高患者参与度和护理连续性的数位健康解决方案。市场是动态的，需要随着消费者偏好的变化和法规的变化而不断适应和研究。企业应注重伙伴关係和协作，以促进创新并提高市场渗透率。提高妇女的健康素养、填补知识空白和支持知情决策也很重要。为了实现永续成长，公司应积极解决女性健康解决方案的可近性和可负担性问题，以满足不同社会经济群体的需求。

市场动态：揭示快速发展的女性健康市场的关键市场洞察

供需的动态交互作用正在改变女性健康市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 女性荷尔蒙失衡与慢性病增加
    • 超级食品趋势不断发展，女性综合维他命的供应增加
    • 女性对天然食品和植物来源食品的偏好
  • 市场限制因素
    • 临床治疗费用上涨
  • 市场机会
    • 活性化研发活动以开发荷尔蒙失调治疗药物
    • 世界各国政府为改善妇女健康所推出的有利政策
  • 市场挑战
    • 与药物摄取相关的副作用

波特五力：驾驭女性健康市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解女性健康市场的外部影响

外部宏观环境因素对女性健康市场的绩效动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解女性健康市场的竞争格局

对女性健康市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵供应商在女性健康市场的绩效评估

FPNV定位矩阵是评估女性健康市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议描绘女性健康市场的成功之路

对于希望加强在全球市场的影响力的公司来说，女性健康市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 女性荷尔蒙失调和慢性疾病增加
      • 超级食品的流行趋势和女性综合维他命供应的增加
      • 女性对天然和植物来源补充品的趋势
    • 抑制因素
      • 临床治疗费用高
    • 机会
      • 活性化旨在开发荷尔蒙失调治疗药物的研发活动
      • 世界各国政府为改善妇女健康推出了有利政策
    • 任务
      • 与药物摄取相关的副作用
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依年龄分類的女性健康市场

  • 13-17岁
  • 18-35岁
  • 36岁以上

第七章 女性保健品市场：依通路划分

  • 医院
  • 在线的
  • 零售

第八章 女性健康市场：依应用分类

  • 避孕药
  • 子宫内膜异位症和子宫肌瘤
  • 荷尔蒙不孕症
  • 闭经
  • 卵巢症候群
  • 停经后骨质疏鬆症

第九章美洲女性健康市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太女性健康市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲女性保健市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 女性健康Start-UpsIron Health 斥资 450 万美元成立。
    • Onsite Women's Health 和 Volpara Health 宣布建立全国伙伴关係。
    • Kiran Mazumdar Shaw 投资女性健康平台 Gytree.com。
    • Bharat Serums and Vaccines 收购了 Firstline Pharma and Genomics，以扩大其在女性健康领域的影响力。
    • Unified Women's Healthcare 收购更年期护理平台 Gennev。
    • 凯雷和 PAI 投资于女性医疗保健。
    • Myovant Sciences 和辉瑞公司的 MYFEMBREE 已获得美国FDA核准，这是一种每日一次的治疗方法，用于治疗与子宫内膜异位症相关的中度至重度疼痛。
    • FemTec Health 收购 Nutrimedy，为其女性健康套件增添个人化营养功能。
    • HempStreet 宣布与 Gynica 建立策略伙伴关係。
    • Organon 计划大幅扩大荷兰长期避孕药具的生产。
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • AbbVie Inc.
  • Agile Therapeutics, Inc.
  • Alembic Pharmaceuticals Ltd.
  • Amgen Inc.
  • Apothecus Pharmaceutical Corp.
  • Ar-Ex Laboratories Pvt. Ltd.
  • AstraZeneca PLC
  • AVA Sciences by FemTec Health Inc.
  • Bayer AG
  • Bharat Serums and Vaccines Ltd.
  • Boston Imaging
  • Cipla Limited
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Ferring BV
  • GE HealthCare
  • Gennev, Inc. by Unified Women's Healthcare
  • Hologic, Inc.
  • Johnson & Johnson Services, Inc.
  • Lupin Limited
  • Mankind Pharma Ltd.
  • Mira by Quanovate Tech Inc.
  • Mylan NV by Viatris
  • Novartis AG
  • Pfizer, Inc.
  • Pregna International Ltd.
  • Quest Diagnostics Incorporated
  • Serum Institute Of India Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens AG
  • Sysmex Asia Pacific Pte Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • The Himalaya Drug Company
  • TherapeuticsMD, Inc.
  • Thermo Fisher Scientific Inc.
  • Torrent Pharmaceuticals Ltd.
  • Triglobal Lifesciences（opc）Pvt. Ltd.
Product Code: MRR-434CCDA04E3D

The Women's Health Market was valued at USD 43.23 billion in 2023, expected to reach USD 46.99 billion in 2024, and is projected to grow at a CAGR of 8.97%, to USD 78.90 billion by 2030.

The women's health market encompasses a broad range of products and services aimed at addressing the unique health needs of women throughout their life stages. This sector includes pharmaceuticals, medical devices, wellness products, diagnostics, and holistic health services targeting areas such as reproductive health, menopause, osteoporosis, and nutritional deficiencies. The necessity of women's health is rooted in the distinct biological and hormonal factors influencing conditions like breast cancer, gynecological disorders, and mental health, thereby necessitating specialized products and treatments. The market is driven by applications in healthcare facilities, homecare, and specialized clinics, catering to an expansive end-users demographic, including teenage girls, young women, pregnant women, and seniors. Key factors influencing market growth include the rising incidence of chronic conditions, increasing healthcare awareness, and technological advancements in healthcare delivery.

KEY MARKET STATISTICS
Base Year [2023] USD 43.23 billion
Estimated Year [2024] USD 46.99 billion
Forecast Year [2030] USD 78.90 billion
CAGR (%) 8.97%

With the aging female population and increasing emphasis on preventive healthcare, significant opportunities lie in personalized medicine and digital health solutions like telemedicine platforms. Companies can capitalize on these trends by investing in AI-driven diagnostics and wearable health trackers. Additionally, the shift towards natural and organic health solutions offers a growing space for innovation. However, the market faces challenges such as stringent regulatory environments, high research and development costs, and socio-economic disparities limiting access to healthcare.

The best areas for innovation include the development of personalized, non-invasive diagnostic tools, especially for hormonal and reproductive disorders, and the integration of digital health solutions to enhance patient engagement and care continuity. The market is dynamic, with shifting consumer preferences and regulatory changes, necessitating continuous adaptation and research. Companies should focus on partnerships and collaborations to foster innovation and improve market penetration. It's also critical to enhance health literacy among women, bridging the knowledge gap to aid informed decision-making. For sustained growth, companies should proactively address the accessibility and affordability of women's health solutions, ensuring they cater to diverse socio-economic groups.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Women's Health Market

The Women's Health Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing cases of hormonal imbalances and chronic diseases in women
    • Rising trend of superfood and increasing availability of multivitamins for women
    • Inclination of women towards natural and plant based health supplements
  • Market Restraints
    • High cost of clinical treatments
  • Market Opportunities
    • Rising R&D activities for drug development to treat the hormonal disorders
    • Favorable policies initiated by governments worlwide to improve women's health
  • Market Challenges
    • Side-effects associated with consumption of drugs

Porter's Five Forces: A Strategic Tool for Navigating the Women's Health Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Women's Health Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Women's Health Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Women's Health Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Women's Health Market

A detailed market share analysis in the Women's Health Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Women's Health Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Women's Health Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Women's Health Market

A strategic analysis of the Women's Health Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Women's Health Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Agile Therapeutics, Inc., Alembic Pharmaceuticals Ltd., Amgen Inc., Apothecus Pharmaceutical Corp., Ar-Ex Laboratories Pvt. Ltd., AstraZeneca PLC, AVA Sciences by FemTec Health Inc., Bayer AG, Bharat Serums and Vaccines Ltd., Boston Imaging, Cipla Limited, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Ferring B.V., GE HealthCare, Gennev, Inc. by Unified Women's Healthcare, Hologic, Inc., Johnson & Johnson Services, Inc., Lupin Limited, Mankind Pharma Ltd., Mira by Quanovate Tech Inc., Mylan N.V. by Viatris, Novartis AG, Pfizer, Inc., Pregna International Ltd., Quest Diagnostics Incorporated, Serum Institute Of India Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens AG, Sysmex Asia Pacific Pte Ltd., Teva Pharmaceutical Industries Ltd., The Himalaya Drug Company, TherapeuticsMD, Inc., Thermo Fisher Scientific Inc., Torrent Pharmaceuticals Ltd., and Triglobal Lifesciences (opc) Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Women's Health Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Age, market is studied across 13-17 Years, 18-35 Years, and 36 Years & Above.
  • Based on Distribution Channel, market is studied across Hospital, Online, and Retail.
  • Based on Application, market is studied across Contraceptives, Endometriosis & Uterine Fibroids, Hormonal Infertility, Menopause, Polycystic Ovary Syndrome, and Postmenopausal Osteoporosis.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of hormonal imbalances and chronic diseases in women
      • 5.1.1.2. Rising trend of superfood and increasing availability of multivitamins for women
      • 5.1.1.3. Inclination of women towards natural and plant based health supplements
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of clinical treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising R&D activities for drug development to treat the hormonal disorders
      • 5.1.3.2. Favorable policies initiated by governments worlwide to improve women's health
    • 5.1.4. Challenges
      • 5.1.4.1. Side-effects associated with consumption of drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Women's Health Market, by Age

  • 6.1. Introduction
  • 6.2. 13-17 Years
  • 6.3. 18-35 Years
  • 6.4. 36 Years & Above

7. Women's Health Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Hospital
  • 7.3. Online
  • 7.4. Retail

8. Women's Health Market, by Application

  • 8.1. Introduction
  • 8.2. Contraceptives
  • 8.3. Endometriosis & Uterine Fibroids
  • 8.4. Hormonal Infertility
  • 8.5. Menopause
  • 8.6. Polycystic Ovary Syndrome
  • 8.7. Postmenopausal Osteoporosis

9. Americas Women's Health Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Women's Health Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Women's Health Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Women's health startup Iron Health launches with $4.5M.
    • 12.3.2. Onsite Women's Health and Volpara Health Announce National Partnership.
    • 12.3.3. Kiran Mazumdar Shaw invests in women's health platform Gytree.com.
    • 12.3.4. Bharat Serums and Vaccines will acquire Firstline Pharma, Genomicks to enhance its presence in women's health segment.
    • 12.3.5. Unified Women's Healthcare acquires menopause care platform Gennev.
    • 12.3.6. Carlyle and PAI on women's healthcare.
    • 12.3.7. Myovant Sciences and Pfizer Receive U.S. FDA Approval of MYFEMBREE, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis.
    • 12.3.8. FemTec Health Acquires Nutrimedy, Adds Personalized Nutrition to Women's Health Suite.
    • 12.3.9. HempStreet announces strategic partnership with Gynica.
    • 12.3.10. Organon is going to significantly expand the production of long-acting contraception in the Netherlands.
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AbbVie Inc.
  • 3. Agile Therapeutics, Inc.
  • 4. Alembic Pharmaceuticals Ltd.
  • 5. Amgen Inc.
  • 6. Apothecus Pharmaceutical Corp.
  • 7. Ar-Ex Laboratories Pvt. Ltd.
  • 8. AstraZeneca PLC
  • 9. AVA Sciences by FemTec Health Inc.
  • 10. Bayer AG
  • 11. Bharat Serums and Vaccines Ltd.
  • 12. Boston Imaging
  • 13. Cipla Limited
  • 14. Eli Lilly and Company
  • 15. F. Hoffmann-La Roche Ltd.
  • 16. Ferring B.V.
  • 17. GE HealthCare
  • 18. Gennev, Inc. by Unified Women's Healthcare
  • 19. Hologic, Inc.
  • 20. Johnson & Johnson Services, Inc.
  • 21. Lupin Limited
  • 22. Mankind Pharma Ltd.
  • 23. Mira by Quanovate Tech Inc.
  • 24. Mylan N.V. by Viatris
  • 25. Novartis AG
  • 26. Pfizer, Inc.
  • 27. Pregna International Ltd.
  • 28. Quest Diagnostics Incorporated
  • 29. Serum Institute Of India Ltd.
  • 30. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 31. Siemens AG
  • 32. Sysmex Asia Pacific Pte Ltd.
  • 33. Teva Pharmaceutical Industries Ltd.
  • 34. The Himalaya Drug Company
  • 35. TherapeuticsMD, Inc.
  • 36. Thermo Fisher Scientific Inc.
  • 37. Torrent Pharmaceuticals Ltd.
  • 38. Triglobal Lifesciences (opc) Pvt. Ltd.

LIST OF FIGURES

  • FIGURE 1. WOMEN'S HEALTH MARKET RESEARCH PROCESS
  • FIGURE 2. WOMEN'S HEALTH MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL WOMEN'S HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY AGE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY AGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. WOMEN'S HEALTH MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. WOMEN'S HEALTH MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. WOMEN'S HEALTH MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL WOMEN'S HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. WOMEN'S HEALTH MARKET DYNAMICS
  • TABLE 7. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY 13-17 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY 18-35 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY 36 YEARS & ABOVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY RETAIL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY ENDOMETRIOSIS & UTERINE FIBROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HORMONAL INFERTILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY POSTMENOPAUSAL OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. WOMEN'S HEALTH MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. WOMEN'S HEALTH MARKET, FPNV POSITIONING MATRIX, 2023